title: Efficacy and safety of SNJ-1656 in primary open-angle glaucoma or ocular hypertension.
authors.affiliation: Department of Ophthalmology, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.
authors.forename: Toshihiro
authors.initials: T
authors.lastname: Inoue
authors.affiliation: Department of Ophthalmology, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.
authors.forename: Hidenobu
authors.initials: H
authors.lastname: Tanihara
authors.affiliation: Senju Pharmaceutical Co, Ltd, Osaka, Japan.
authors.forename: Hideki
authors.initials: H
authors.lastname: Tokushige
authors.affiliation: Kanto Central Hospital of the Mutual Aid Association of Public School Teachers, Tokyo, Japan.
authors.forename: Makoto
authors.initials: M
authors.lastname: Araie
mesh_terms: D000287:Administration, Topical; D000328:Adult; D000368:Aged; D000959:Antihypertensive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D004311:Double-Blind Method; D005260:Female; D005902:Glaucoma, Open-Angle / Q000188:drug therapy*; D006801:Humans; D007429:Intraocular Pressure / Q000187:drug effects*; D008297:Male; D008875:Middle Aged; D009798:Ocular Hypertension / Q000188:drug therapy*; D009883:Ophthalmic Solutions; D011725:Pyridines / Q000009:adverse effects / Q000627:therapeutic use*; D014065:Tonometry, Ocular; D055815:Young Adult; D054460:rho-Associated Kinases / Q000037:antagonists & inhibitors*
chemical_list: D000959:Antihypertensive Agents; D009883:Ophthalmic Solutions; D011725:Pyridines; C520365:Y-39983; D054460:rho-Associated Kinases